- Home
- GTX vs SLNO Comparison
GTX vs SLNO Comparison
Compare GTX & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTX
- SLNO
- Stock Information
- Founded
- GTX 2018
- SLNO 1999
- Country
- GTX Switzerland
- SLNO United States
- Employees
- GTX N/A
- SLNO N/A
- Industry
- GTX Auto Parts:O.E.M.
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GTX Consumer Discretionary
- SLNO Health Care
- Exchange
- GTX Nasdaq
- SLNO Nasdaq
- Market Cap
- GTX 1.8B
- SLNO 1.9B
- IPO Year
- GTX N/A
- SLNO 2014
- Fundamental
- Price
- GTX $8.31
- SLNO $57.78
- Analyst Decision
- GTX Strong Buy
- SLNO Strong Buy
- Analyst Count
- GTX 1
- SLNO 7
- Target Price
- GTX $12.00
- SLNO $69.86
- AVG Volume (30 Days)
- GTX 869.0K
- SLNO 515.2K
- Earning Date
- GTX 10-24-2024
- SLNO 11-06-2024
- Dividend Yield
- GTX N/A
- SLNO N/A
- EPS Growth
- GTX N/A
- SLNO N/A
- EPS
- GTX 1.01
- SLNO N/A
- Revenue
- GTX $3,576,000,000.00
- SLNO N/A
- Revenue This Year
- GTX N/A
- SLNO N/A
- Revenue Next Year
- GTX $3.10
- SLNO N/A
- P/E Ratio
- GTX $8.21
- SLNO N/A
- Revenue Growth
- GTX N/A
- SLNO N/A
- 52 Week Low
- GTX $7.13
- SLNO $26.38
- 52 Week High
- GTX $10.16
- SLNO $59.75
- Technical
- Relative Strength Index (RSI)
- GTX 63.40
- SLNO 60.42
- Support Level
- GTX $7.72
- SLNO $50.69
- Resistance Level
- GTX $8.13
- SLNO $59.75
- Average True Range (ATR)
- GTX 0.24
- SLNO 2.58
- MACD
- GTX 0.07
- SLNO -0.18
- Stochastic Oscillator
- GTX 89.72
- SLNO 78.22
About GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.